{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T12:07:27Z","timestamp":1783339647905,"version":"3.54.6"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-025-11196-6","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:55:22Z","timestamp":1761731722000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Upregulation and diagnostic potential of Interleukin-36 cytokine isoforms in dilated cardiomyopathy: evidence from human and murine models"],"prefix":"10.1007","volume":"53","author":[{"given":"Alishba","family":"Kainat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mubeen Tabish","family":"Nasim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fazlul Aziz","family":"Mian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Muhammad","family":"Nurulain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassaan Mehboob","family":"Awan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahir","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabir","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"key":"11196_CR1","doi-asserted-by":"publisher","first-page":"898978","DOI":"10.3389\/fnut.2022.898978","volume":"9","author":"BW Nawsherwan","year":"2022","unstructured":"Nawsherwan BW, Le Z, Mubarik S, Fu G, Wang Y (2022) Prediction of cardiovascular diseases mortality- and disability-adjusted life-years attributed to modifiable dietary risk factors from 1990 to 2030 among East Asian countries and the world. Front Nutr 9:898978. https:\/\/doi.org\/10.3389\/fnut.2022.898978","journal-title":"Front Nutr"},{"issue":"1","key":"11196_CR2","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s44197-021-00024-2","volume":"12","author":"Z Wang","year":"2022","unstructured":"Wang Z, Du A, Liu H, Wang Z, Hu J (2022) Systematic analysis of the global, regional and national burden of cardiovascular diseases from 1990 to 2017. J Epidemiol Glob Health 12(1):92\u2013103. https:\/\/doi.org\/10.1007\/s44197-021-00024-2","journal-title":"J Epidemiol Glob Health"},{"issue":"2","key":"11196_CR3","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","volume":"29","author":"P Elliott","year":"2008","unstructured":"Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P et al (2008) Classification of the cardiomyopathies: a position statement from the European society of cardiology working group on myocardial and pericardial diseases. Eur Heart J 29(2):270\u2013276. https:\/\/doi.org\/10.1093\/eurheartj\/ehm342","journal-title":"Eur Heart J"},{"issue":"6","key":"11196_CR4","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nrg.2016.160","volume":"18","author":"AV Khera","year":"2017","unstructured":"Khera AV, Kathiresan S (2017) Genetics of coronary artery disease: discovery, biology and clinical translation. Nat Rev Genet 18(6):331\u2013344. https:\/\/doi.org\/10.1038\/nrg.2016.160","journal-title":"Nat Rev Genet"},{"issue":"1","key":"11196_CR5","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/joim.13556","volume":"34","author":"X Guo","year":"2023","unstructured":"Guo X, Ma L (2023) Inflammation in coronary artery disease-clinical implications of novel HDL-cholesterol\u2013related inflammatory parameters as predictors. Coron Artery Dis 34(1):66. https:\/\/doi.org\/10.1111\/joim.13556","journal-title":"Coron Artery Dis"},{"issue":"1","key":"11196_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/joim.13556","volume":"293","author":"D Harding","year":"2023","unstructured":"Harding D, Chong MHA, Lahoti N, Bigogno CM, Prema R, Mohiddin SA et al (2023) Dilated cardiomyopathy and chronic cardiac inflammation: pathogenesis, diagnosis and therapy. J Intern Med 293(1):23\u201347. https:\/\/doi.org\/10.1111\/joim.13556","journal-title":"J Intern Med"},{"issue":"7","key":"11196_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59071246","volume":"59","author":"E Wang","year":"2023","unstructured":"Wang E, Zhou R, Li T, Hua Y, Zhou K, Li Y et al (2023) The molecular role of immune cells in dilated cardiomyopathy. Medicina (Kaunas) 59(7):1246. https:\/\/doi.org\/10.3390\/medicina59071246","journal-title":"Medicina (Kaunas)"},{"issue":"10","key":"11196_CR8","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1159\/000525845","volume":"183","author":"S Kazemian","year":"2022","unstructured":"Kazemian S, Ahmadi R, Rafiei A, Azadegan-Dehkordi F, Khaledifar A, Abdollahpour-Alitappeh M et al (2022) The serum levels of IL-36 in patients with coronary artery disease and their correlation with the serum levels of IL-32, IL-6, TNF-\u03b1, and oxidative stress. Int Arch Allergy Immunol 183(10):1137\u20131145. https:\/\/doi.org\/10.1159\/000525845","journal-title":"Int Arch Allergy Immunol"},{"issue":"17","key":"11196_CR9","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1016\/j.jacc.2013.12.030","volume":"63","author":"S Tsimikas","year":"2014","unstructured":"Tsimikas S, Duff GW, Berger PB, Rogus J, Huttner K, Clopton P et al (2014) Pro-inflammatory interleukin-1 genotypes potentiate the risk of coronary artery disease and cardiovascular events mediated by oxidized phospholipids and lipoprotein(a). J Am Coll Cardiol 63(17):1724\u20131734. https:\/\/doi.org\/10.1016\/j.jacc.2013.12.030","journal-title":"J Am Coll Cardiol"},{"issue":"17\u201318","key":"11196_CR10","doi-asserted-by":"publisher","first-page":"6215","DOI":"10.1007\/s00018-021-03909-4","volume":"78","author":"J Byrne","year":"2021","unstructured":"Byrne J, Baker K, Houston A, Brint E (2021) IL-36 cytokines in inflammatory and malignant diseases: not the new kid on the block anymore. Cell Mol Life Sci 78(17\u201318):6215\u20136227. https:\/\/doi.org\/10.1007\/s00018-021-03909-4","journal-title":"Cell Mol Life Sci"},{"key":"11196_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2021.155630","volume":"146","author":"M Zhang","year":"2021","unstructured":"Zhang M, Liu J, Gao R, Hu Y, Lu L, Liu C et al (2021) Interleukin-36\u03b3 aggravates macrophage foam cell formation and atherosclerosis progression in ApoE knockout mice. Cytokine 146:155630. https:\/\/doi.org\/10.1016\/j.cyto.2021.155630","journal-title":"Cytokine"},{"key":"11196_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1642116","volume":"16","author":"H Zhang","year":"2025","unstructured":"Zhang H, Huang W, Bao S (2025) Dichotomous roles of IL-36 and IL-38 in cardiovascular disease. Front Immunol 16:1642116. https:\/\/doi.org\/10.3389\/fimmu.2025.1642116","journal-title":"Front Immunol"},{"key":"11196_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02532","volume":"10","author":"ZC Yuan","year":"2019","unstructured":"Yuan ZC, Xu WD, Liu XY, Liu XY, Huang AF, Su LC (2019) Biology of IL-36 signaling and its role in systemic inflammatory diseases. Front Immunol 10:2532. https:\/\/doi.org\/10.3389\/fimmu.2019.02532","journal-title":"Front Immunol"},{"key":"11196_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2024.156808","volume":"185","author":"W Zhou","year":"2025","unstructured":"Zhou W, Li X, Zhou H, Hu Y, Chen Y, Guo D (2025) TNF-\u03b1\/IL-1\u03b2\/IL-1\u03b1\/IL-12 inflammatory cytokine axes coupled with TLR1\/TLR3\/TLR5\/MYD88 immune signaling pathway over-activation contribute to simultaneous carotid and coronary artery and occlusion in elderly patients. Cytokine 185:156808. https:\/\/doi.org\/10.1016\/j.cyto.2024.156808","journal-title":"Cytokine"},{"issue":"2","key":"11196_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25021082","volume":"25","author":"H Zhang","year":"2024","unstructured":"Zhang H, Dhalla NS (2024) The role of pro-inflammatory cytokines in the pathogenesis of cardiovascular disease. Int J Mol Sci 25(2):1082. https:\/\/doi.org\/10.3390\/ijms25021082","journal-title":"Int J Mol Sci"},{"issue":"2","key":"11196_CR16","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1089\/bio.2014.0062","volume":"13","author":"YH Hong","year":"2015","unstructured":"Hong YH, Martin LA, Mulvaney JM, Burhans MS, Blaxall BC, Hinton RB (2015) RNA extraction from healthy and failing human myocardium: a comparative evaluation. Biopreserv Biobank 13(2):123\u2013130. https:\/\/doi.org\/10.1089\/bio.2014.0062","journal-title":"Biopreserv Biobank"},{"issue":"25","key":"11196_CR17","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM et al (2020) Global burden of cardiovascular diseases and risk Factors, 1990\u20132019: update from the GBD 2019 study. J Am Coll Cardiol 76(25):2982\u20133021. https:\/\/doi.org\/10.1016\/j.jacc.2020.11.010","journal-title":"J Am Coll Cardiol"},{"issue":"38","key":"11196_CR18","doi-asserted-by":"publisher","first-page":"4063","DOI":"10.2174\/1381612825666190925163827","volume":"25","author":"GD Flora","year":"2019","unstructured":"Flora GD, Nayak MK (2019) A brief review of cardiovascular diseases, associated risk factors and current treatment regimes. Curr Pharm Des 25(38):4063\u20134084. https:\/\/doi.org\/10.2174\/1381612825666190925163827","journal-title":"Curr Pharm Des"},{"issue":"9","key":"11196_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ph16091242","volume":"16","author":"CS Figueiredo","year":"2023","unstructured":"Figueiredo CS, Roseira ES, Viana TT, Silveira MAD, de Melo RMV, Fernandez MG et al (2023) Inflammation in coronary atherosclerosis: insights into pathogenesis and therapeutic potential of anti-inflammatory drugs. Pharmaceuticals (Basel) 16(9):1242. https:\/\/doi.org\/10.3390\/ph16091242","journal-title":"Pharmaceuticals (Basel)"},{"issue":"5","key":"11196_CR20","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.155236","volume":"7","author":"J El-Awaisi","year":"2022","unstructured":"El-Awaisi J, Kavanagh DP, Rink MR, Weston CJ, Drury NE, Kalia N (2022) Targeting IL-36 improves age-related coronary microcirculatory dysfunction and attenuates myocardial ischemia\/reperfusion injury in mice. JCI Insight 7(5):e155236. https:\/\/doi.org\/10.1172\/jci.insight.155236","journal-title":"JCI Insight"},{"issue":"5","key":"11196_CR21","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1002\/pro.2441","volume":"23","author":"B Krumm","year":"2014","unstructured":"Krumm B, Xiang Y, Deng J (2014) Structural biology of the IL-1 superfamily: key cytokines in the regulation of immune and inflammatory responses. Protein Sci 23(5):526\u2013538. https:\/\/doi.org\/10.1002\/pro.2441","journal-title":"Protein Sci"},{"key":"11196_CR22","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.smim.2013.11.003","volume":"25","author":"MS Gresnigt","year":"2013","unstructured":"Gresnigt MS, Van De Veerdonk FL (2013) Biology of IL-36 cytokines and their role in disease. Semin Immunol 25:458\u2013465. https:\/\/doi.org\/10.1016\/j.smim.2013.11.003","journal-title":"Semin Immunol"},{"key":"11196_CR23","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/imr.12610","volume":"281","author":"EY Bassoy","year":"2018","unstructured":"Bassoy EY, Towne JE, Gabay C (2018) Regulation and function of interleukin-36 cytokines. Immunol Rev 281:169\u2013178. https:\/\/doi.org\/10.1111\/imr.12610","journal-title":"Immunol Rev"},{"key":"11196_CR24","doi-asserted-by":"publisher","first-page":"19588","DOI":"10.3390\/molecules201019588","volume":"20","author":"M Chu","year":"2015","unstructured":"Chu M, Wong CK, Cai Z, Dong J, Jiao D, Kam NW et al (2015) Elevated expression and pro-inflammatory activity of IL-36 in patients with systemic lupus erythematosus. Molecules 20:19588\u201319604. https:\/\/doi.org\/10.3390\/molecules201019588","journal-title":"Molecules"},{"key":"11196_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20133318","author":"S Madonna","year":"2019","unstructured":"Madonna S, Girolomoni G, Dinarello CA, Albanesi C (2019) The significance of IL-36 hyperactivation and IL-36R targeting in psoriasis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20133318","journal-title":"Int J Mol Sci"},{"issue":"2","key":"11196_CR26","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/cei.12761","volume":"184","author":"MA Boutet","year":"2016","unstructured":"Boutet MA, Bart G, Penhoat M, Amiaud J, Brulin B, Charrier C, Morel F, Lecron JC, Rolli-Derkinderen M, Bourreille A, Vigne S, Gabay C, Palmer G, Le Goff B, Blanchard F (2016) Distinct expression of Interleukin (IL)-36\u03b1, \u03b2 and \u03b3, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and crohn\u2019s disease. Clin Exp Immunol 184(2):159\u2013173. https:\/\/doi.org\/10.1111\/cei.12761","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"11196_CR27","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2023.11974","volume":"25","author":"M Li","year":"2023","unstructured":"Li M, Jiang W, Wang Z, Lu Y, Zhang J (2023) New insights on IL-36 in intestinal inflammation and colorectal cancer (Review). Exp Ther Med 25(6):275. https:\/\/doi.org\/10.3892\/etm.2023.11974","journal-title":"Exp Ther Med"},{"issue":"2","key":"11196_CR28","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.18632\/oncotarget.22814","volume":"9","author":"L Ding","year":"2017","unstructured":"Ding L, Wang X, Hong X, Lu L, Liu D (2017) IL-36 cytokines in autoimmunity and inflammatory disease. Oncotarget 9(2):2895\u20132901. https:\/\/doi.org\/10.18632\/oncotarget.22814","journal-title":"Oncotarget"},{"issue":"10","key":"11196_CR29","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1111\/jdv.19935","volume":"38","author":"K Sugiura","year":"2024","unstructured":"Sugiura K, Fujita H, Komine M, Yamanaka K, Akiyama M (2024) The role of interleukin-36 in health and disease states. J Eur Acad Dermatol Venereol 38(10):1910\u20131925. https:\/\/doi.org\/10.1111\/jdv.19935","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"11196_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s13223-023-00834-y","volume":"19","author":"J Gu","year":"2023","unstructured":"Gu J, Qin G, Jiang L, Xu W, Wang Y, Liao J et al (2023) Correlations between IL-36 family cytokines in peripheral blood and subjective and objective assessment results in patients with allergic rhinitis. Allergy Asthma Clin Immunol 19(1):79. https:\/\/doi.org\/10.1186\/s13223-023-00834-y","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"6","key":"11196_CR31","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/crj.13338","volume":"15","author":"W Li","year":"2021","unstructured":"Li W, Meng X, Hao Y, Chen M, Jia Y, Gao P (2021) Elevated sputum IL-36 levels are associated with neutrophil-related inflammation in COPD patients. Clin Respir J 15(6):648\u2013656. https:\/\/doi.org\/10.1111\/crj.13338","journal-title":"Clin Respir J"},{"key":"11196_CR32","doi-asserted-by":"publisher","unstructured":"Akbari T, Kazemi Fard T, Fadaei R, Rostami R, Moradi N, Movahedi M et al (2023) Evaluation of MMP-9, IL-6, TNF-\u03b1 levels and peripheral blood mononuclear cells genes expression of MMP-9 and TIMP-1 in Iranian patients with coronary artery disease. J Cardiovasc Thorac Res. 15(4):223\u201330. https:\/\/doi.org\/10.34172\/jcvtr.2023.31844","DOI":"10.34172\/jcvtr.2023.31844"},{"issue":"1","key":"11196_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-46338-y","volume":"13","author":"B Qi","year":"2023","unstructured":"Qi B, Yang ZJ, Huang N, Zheng WB, Gui C (2023) Exploring the diagnostic and prognostic value of the C-reactive protein\/lymphocyte ratio for dilated cardiomyopathy based on a real-world study. Sci Rep 13(1):18889. https:\/\/doi.org\/10.1038\/s41598-023-46338-y","journal-title":"Sci Rep"},{"key":"11196_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/jcdd10060225","volume":"10","author":"N Salerno","year":"2023","unstructured":"Salerno N, Scalise M, Marino F, Filardo A, Chiefalo A, Panuccio G, Torella M, De Angelis A, De Rosa S, Ellison-Hughes GM et al (2023) A mouse model of dilated cardiomyopathy produced by isoproterenol acute exposure followed by 5-fluorouracil administration. J Cardiovasc Dev Dis 10:225. https:\/\/doi.org\/10.3390\/jcdd10060225","journal-title":"J Cardiovasc Dev Dis"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11196-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-11196-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11196-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:55:22Z","timestamp":1761731722000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-11196-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11196"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-11196-6","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]},"assertion":[{"value":"6 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animals procedure involving rat models were approved by the Institutional Animal Care and Use Committee (IACUC) and followed the guidelines set by the National Institute of Health Guide for the Care and Use of Laboratory Animal (Approval Number: No. F.1\u20135\/ERC\/2023) (DY No. 6711).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval\u00a0<!--Emphasis Type='Bold' removed-->for Animals Experiments."}},{"value":"The protocol adhered to this study was according to the Declaration of Helsinki revised in 2013, and approved by the Ethical Review Board (ERB) of Department of Biosciences, COMSATA University Islamabad (Approval Number: CUI\/Bio\/ERB\/2022\/1) and Ethics Review Committee (ERC), Department of Cardiology, Pakistan Institute of Medical Sciences Islamabad (PIMS) (Approval Number: PIMS\/CARD-2023-10). All human subjects provided written informed consent before inclusion in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate\u00a0<!--Emphasis Type='Bold' removed-->(Human Subjects)."}},{"value":"Not Applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"28"}}